The project, funded by the European Union and endowed with a budget of 24.8 million euros, aims to identify a large set of biomarkers that allow liver disease to be detected in the earliest stages, an...
Read moreThe combination of surgery with adjuvant immunotherapy, after surgery, was shown to improve disease-free survival rates in the last IMbrave 050 phase III study
Read morePublished in the journal The Lancet, the study presents the results of Abatacept, a drug that modulates the activation of T cells, which play a key role in the progression of the disease.
Read moreThe DEFINITIVE project, led by IDIBAPS, will be conducted across 44 hospitals in a total of 7 European and associated countries to demonstrate that use of genomic test HER2DX® improves quality of lif...
Read moreEndowed with 1.25 million euros, the project is coordinated by IDIBAPS’ Clinical Addictions Research Group (GRAC-GRE), which is led by Hugo López-Pelayo, a researcher and medical specialist at Hosp...
Read moreThe study shows an upward trend in emergency admissions related to eating disorders, self-harm and suicide ideation and attempts, particularly among female adolescents.
Read moreAn international team, co-led by the Hospital Clínic-IDIBAPS, has identified four biomarkers that determine the risk of the recurrence of this cancer after CAR T-cell therapy.
Read moreThe research provides the most comprehensive cellular map to date of the human tonsil, increasing our understanding of immune response to disease, and perception of immune system related diseases such...
Read moreIt has been shown that the administration of individualised pulmonary ventilation strategies for each patient, adjusting respiratory support to individual needs during the intraoperative and immediate...
Read moreResearch team has described that the ZEB1 and ZEB2 proteins oppositely regulate muscle adaptation to energy needs during fasting.
Read moreThe goal of the KAIROS project, driven by 6 Clínic-IDIBAPS research groups, will be to enhance molecular and genetic knowledge about various diseases and facilitate the translation of this knowledge ...
Read moreThe ultimate goal of THRIVE is to improve the survival rates of both paediatric and adult liver cancer patients by understanding at-risk populations and tumour-host interactions and developing biomark...
Read more